Open access · OA
via Europe PMC
Complement C3 is associated with cancer-induced frailty: genetic and clinical evidence
Zhang C, Zhao T, Li W, Shi Z, Bao Z.
Frontiers in nutrition
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
C, Z., T, Z., W, L., Z, S., & Z., B. (n.d.). Complement C3 is associated with cancer-induced frailty: genetic and clinical evidence. <em>Frontiers in nutrition</em>. https://europepmc.org/article/PMC/PMC13661479
Vancouver
C Z, T Z, W L, Z S, Z. B. Complement C3 is associated with cancer-induced frailty: genetic and clinical evidence. Frontiers in nutrition.
BibTeX
@article{zhangndComple,
title = {Complement C3 is associated with cancer-induced frailty: genetic and clinical evidence},
author = {Zhang C and Zhao T and Li W and Shi Z and Bao Z.},
journal = {Frontiers in nutrition},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical Liver Disease 2022
Open access · OA
Intermittent Fasting as a Treatment for Nonalcoholic Fatty Liver Disease: What Is the Evidence?
Research Square 2026
Preprint · CC-BY
Elevated serum gamma-glutamyl transferase and frailty risk: evidence from prospective cohort, metabolomic, and integrative genetic evidence
The journal of prevention of Alzheimer's disease 2026
Open access · OA
Integrating frailty into decision-making for disease-modifying therapies in Alzheimer's disease: a proposed expert-opinion based approach.
Expert Opinion on Biological Therapy 2019
Citation only
Stem cell therapies for wound healing
Biogerontology 2018
Citation only
Metformin as a geroprotector: experimental and clinical evidence
University of Limerick 2026
Open access · US-GOV